Education
About Us
Working with TipRanks
Follow Us
Intercure (IL:INCR)
NASDAQ:INCR
INCR Stock Chart & Stats
514.20
>-0.01(-0.10%)
At close: 4:00 PM EST
514.20
>-0.01(-0.10%)
Day’s Range― - ―
52-Week Range396.40 - 670.00
Previous CloseN/A
Volume249.40K
Average Volume (3M)88.67K
Market Cap
240.54M
Enterprise Value368.83M
Total Cash (Recent Filing)51.58M
Total Debt (Recent Filing)179.34M
Price to Earnings (P/E)―
Beta1.18
Next Earnings
Apr 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.60
Shares Outstanding54,681,335
10 Day Avg. Volume127,628
30 Day Avg. Volume88,666
Financial Highlights & Ratios
PEG Ratio-0.43
Price to Book (P/B)0.65
Price to Sales (P/S)1.09
P/FCF Ratio-3.64
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Intercure News
INCR FAQ
What was Intercure’s price range in the past 12 months?
Intercure lowest stock price was 396.40 and its highest was 670.00 in the past 12 months.
What is Intercure’s market cap?
Intercure’s market cap is 240.54M.
When is Intercure’s upcoming earnings report date?
Intercure’s upcoming earnings report date is Apr 30, 2026 which is in 133 days.
How were Intercure’s earnings last quarter?
Intercure released its earnings results on Oct 08, 2025. The company reported -3.6 earnings per share for the quarter, missing the consensus estimate of N/A by -3.6.
Is Intercure overvalued?
According to Wall Street analysts Intercure’s price is currently Overvalued.
Does Intercure pay dividends?
Intercure does not currently pay dividends.
What is Intercure’s EPS estimate?
Intercure’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Intercure have?
Intercure has 54,681,335 shares outstanding.
What happened to Intercure’s price movement after its last earnings report?
Intercure reported an EPS of -3.6 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.739%.
Which hedge fund is a major shareholder of Intercure?
Currently, no hedge funds are holding shares in IL:INCR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Intercure Stock Smart Score
Company Description
Intercure
Intercure (INCR) is a leading company in the medical cannabis sector, primarily focused on the research, development, and distribution of cannabis-based products for therapeutic use. The company operates in the rapidly growing cannabis market, particularly in Israel and other international jurisdictions, providing a range of high-quality medical cannabis products tailored to various patient needs. Intercure's core offerings include cannabis flower, oils, and other formulations, aimed at improving the quality of life for patients with chronic conditions.